Who Paid My Doc
Comirnaty
Biological Vaccines
NDC 0069-1000-02
General payments
$5,864,775
Research payments
$251,909,789
Through program year 2025, $5,864,775 in general payments and $251,909,789 in research payments were reported against Comirnaty (Vaccines).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,327,188 | 53,946 |
| 2025 | Research | $7,163,739 | 601 |
| 2024 | General | $1,314,888 | 60,295 |
| 2024 | Research | $17,125,692 | 1,317 |
| 2023 | General | $2,398,152 | 132,741 |
| 2023 | Research | $61,493,545 | 3,828 |
| 2022 | General | $824,547 | 31,694 |
| 2022 | Research | $165,845,282 | 5,962 |
| 2021 | Research | $281,530 | 22 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 148 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
278,676 general · 11,730 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.